The Ministry of Industry and Trade of the Russian Federation announced the transfer of analog insulin production technologies from "Geropharm" (St. Petersburg) to the Karaganda Pharmaceutical Complex.
«In the presence of Deputy Prime Minister Denis Manturov, a ceremony was held to sign a long-term license agreement granting the Karaganda Pharmaceutical Complex the right to use the trade secret for the production of analog insulin from "Geropharm" and the transfer of production technology», the Ministry of Industry and Trade writes.
It is noted that the stages of bottling and packaging will be localized at the Kazakhstan plant, and the first commercial product will appear by the end of 2024.